Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Mint Med vs Precision Telemed

Two GLP-1 desks, one scoreboard. We put Mint Med and Precision Telemed head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 52 · Grade C

Mint Med

Visit Mint Med Full brief →

FDA warning letter, June 2026 — issued to Glow Medispa, LLC dba Mint Med. See the FDA's warning letter database.

vs
Higher Brief ScoreNo. 24 · Grade B

Precision Telemed

Visit Precision Telemed Full brief →

The verdict

Precision Telemed takes this head-to-head.

Precision Telemed scores 85 to 79 on our six-factor Brief Score — A LegitScript-certified, nationwide desk with clean mid-low pricing on both molecules.

That doesn't make Mint Med a bad call — it's best for readers who want flat $159 all-doses compounded glp-1 with no membership. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
78
85
Supply Reliability
79
85
Transparency
88
87
Access Breadth
74
87
Clinical Oversight
86
86
Track Record
65
81
Mint MedBrief Score 79 · 85Precision Telemed

Price, coverage & the tracker

Mint MedPrecision Telemed
Brief Score79/100 (C)85/100 (B)
Semaglutide$159/mo$149/mo
Tirzepatide$159/mo$199/mo
Coverage36 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerNewnew to the tracker, no prior readingStableprice stable

Mint Med: New to the tracker on 1 August 2026. The published line reads $159/mo at our first reading; there is no earlier reading of ours to compare it against yet.

Precision Telemed: $149 sema / $199 tirz nationwide; LegitScript-certified.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.